VPE-001

N/A

Report date: 2025/01/26 17:27:17
NME

Base Information

Drug NameVPE-001
Drug Alias NameVPE-001
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUterine FibroidsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViteava Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesViteava Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsUterine FibroidsLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A